Figure 3From: Constitutive activation of glycogen synthase kinase-3β correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer Protein expressions of pGSK-3β and cyclin D1 in SNU-668 gastric cancer cells. Cells were treated with or without a GSK-3β inhibitor LiCl (30 mM) for 48 hours and immunoblot analysis was performed for pGSK-3β and cyclin D1. β-actin was used as internal control.Back to article page